Alpha Mark Advisors, LLC Abbott Laboratories Transaction History

Alpha Mark Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$105.0 - $114.42 $27,825 - $30,321	-265 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $17,457 - $22,344	228 Added 616.22%	265 $24,000
Q1 2020 Apr 24, 2020	BUY	$62.82 - $91.86 $2,324 - $3,398	37 New	37 $3,000
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $6,081 - $7,336	-100 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$48.06 - $53.64 $4,806 - $5,364	100	100 $5,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Mark Advisors, LLC with notifications on news.